Evaluation and testing services (ETS) for vaccines

Award Notice Posted

Solicitation number
7529
Agency
Awarded
to Bioqual, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N93025D00031 Federal IDV award
NAICS code
Not on record
PSC
Not on record
Place of performance
Maryland 20850, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, awarded Contract 75N93025D00031 to BIOQUAL, INC. on September 30, 2025, for Evaluation and Testing Services (ETS) for Vaccines. This Indefinite Delivery, Indefinite Quantity (IDIQ) contract includes a guaranteed minimum of $10,000 with a maximum ordering limit of $136,578,701, establishing a significant long-term vehicle for vaccine evaluation and testing services. The initial obligation on the base IDIQ contract award was $10,000, with the potential for substantial future obligations through the contract's maximum ordering limit. This contract supports NIAID's mission to develop and evaluate vaccine candidates and related testing methodologies.

Notice text

- IDIQ Guaranteed Minimum: $10,000 - Amount Obligated on Base IDIQ Contract Award

- Maximum Ordering Limit: $136,578,701

Awarded contract 75N93025D00031 to BIOQUAL, INC. for 10000.00 on 2025-09-30.

Notice history

5 of 13 notices listed here. See the rest on GovTribe.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity